DigestRedComo funciona
Red
/
Empresas
Sa
No verificado

Savara Inc.

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaMedicina - VariosSalud

84 Comunicados de prensa

Ver todos los comunicados de prensa
12/06/2026
Mercado de valores
Finanzas
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Savara Announces New Employment Inducement Grant
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
08/06/2026
Mercado laboral
Biotecnología
Farmacéutica
Salud
Savara Announces Chief Financial and Administrative Officer Transition
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
27/05/2026
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Eventos
Web y redes sociales
Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
20/05/2026
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Eventos
Industria
Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
19/05/2026
Eventos
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
18/05/2026
Eventos
Ferias y Congresos
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Savara Announces New Exercise Capacity Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
12/05/2026
Mercado de valores
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Savara Reports First Quarter Financial Results and Provides Business Update
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
11/05/2026
Web y redes sociales
Eventos
Ferias y Congresos
Biotecnología
Farmacéutica
Salud
Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
17/04/2026
Mercado de valores
Finanzas
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Savara Announces New Employment Inducement Grant
Fuente
Savara Inc.
Editor
Business Wire
1.00
0
15/04/2026
Industria
Biotecnología
Higiene alimentaria
Salud
Farmacéutica
Medicina - Varios
Savara Announces the U.S. Food & Drug Administration (FDA) Has Extended the Review Period for the Molgramostim Inhalation Solution (Molgramostim) Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Fuente
Savara Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0